Laroscorbine is used to prevent vitamin C deficiency in patients fed exclusively by infusion.
Posology:
1 injectable ampoule per day
Mode of administration:
Intravenous route only. Oral administration is preferred as soon as possible. Otherwise, injection should be done by a healthcare professional. Contraindications:
- Hypersensitivity to the active substance or any of the excipients
- Nephrolithiasis or a history of nephrolithiasis, especially oxalocalcic renal lithiasis
- Hyperoxaluria - Severe renal impairment (creatinine clearance < 30 ml/min)
Fertility, pregnancy, and lactation:
Pregnancy
In the clinical setting, a significant amount of hindsight and sufficiently large numbers of exposed pregnancies have not revealed any malformative or fetotoxic effects of vitamin C. However, no well-controlled studies of vitamin C in pregnant women have been conducted. As a precautionary measure, it is preferable to avoid the use of LAROSCORBINE 1 g/5 mL, I.V. injectable solution in ampules, during pregnancy.
Lactation
Vitamin C is excreted in breast milk. There are insufficient data on the effects of vitamin C in neonates/infants. Therefore, it is best to avoid the use of LAROSCORBINE 1 g/5 mL, I.V. injectable solution in ampules, during breastfeeding.
Fertility
There are no data regarding the effects of LAROSCORBINE 1 g/5 mL, I.V. injectable solution in ampules on human fertility.
It is imperative that you read the package insert carefully before use